Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

29.3K
The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.3K
Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

8.0K
The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
8.0K
Electric Potential and Potential Difference01:16

Electric Potential and Potential Difference

5.6K
Suppose a positive test charge moves away from a positive static charge, then the Coulomb force does positive work, and its electric potential energy decreases. The potential energy per unit charge is defined as the electric potential. The electric potential is independent of the test charge.
When a test charge moves from the initial to the final position, the electric potential difference between those positions is defined as the ratio of the change in the potential energy to the charge on the...
5.6K
Identifying Statistically Significant Differences: The F-Test01:14

Identifying Statistically Significant Differences: The F-Test

3.1K
The F-test is used to compare two sample variances to each other or compare the sample variance to the population variance. It is used to decide whether an indeterminate error can explain the difference in their values. The underlying assumptions that allow the use of the F-test include the data set or sets are normally distributed, and the data sets are independent of each other. The test statistic F is calculated by dividing one variance by another. In other words, the square of one standard...
3.1K
Sum and Difference OpAmps01:22

Sum and Difference OpAmps

1.3K
Operational amplifiers (op-amps) are versatile devices that extend beyond amplification. In this context, two specific op-amp configurations are explored: the summing and difference amplifiers.
A summing amplifier, or an adder, utilizes an op-amp to merge multiple input signals into a single output signal. When audio signals are introduced into its input channels, the input resistors initiate currents that traverse feedback resistors, resulting in an output voltage. Applying Kirchhoff's current...
1.3K
Difference Equation Solution using z-Transform01:24

Difference Equation Solution using z-Transform

625
The z-transform is a powerful tool for analyzing practical discrete-time systems, often represented by linear difference equations. Solving a higher-order difference equation requires knowledge of the input signal and the initial conditions up to one term less than the order of the equation.
The z-transform facilitates handling delayed signals by shifting the signal in the z-domain, which corresponds to delaying the signal in the time domain, and advancing signals by similarly shifting in the...
625

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging.

World journal of surgery·2019
Same author

Corrigendum to: Can ARFI of the liver and spleen predict the presence of gastroesophageal varies? [Clin Radiol 73 (12) (2018) 1046-1051].

Clinical radiology·2018
Same author

Can acoustic radiation force imaging of the liver and spleen predict the presence of gastroesophageal varices?

Clinical radiology·2018
Same author

Measured and perceived indices of fluid balance in professional athletes. The use and impact of hydration assessment strategies.

European journal of sport science·2018
Same author

COMPARATIVE POPULATION GENETIC STRUCTURE OF A PARASITE (FASCIOLOIDES MAGNA) AND ITS DEFINITIVE HOST.

Evolution; international journal of organic evolution·2017
Same author

Incidence and implications of chemotherapy related hand-foot syndrome.

Expert opinion on drug safety·2016
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.2K

Racial Differences in Accepting Pegfilgrastim Onpro Kit (On-Body Injector) Use Among Cancer Patients.

M W Saif1, D W Hackenyos2, M H Smith2

  • 1Northwell Health Cancer Institute, Lake Success, NY, USA.

Clinics of Oncology
|August 14, 2019
PubMed
Summary
This summary is machine-generated.

The Neulasta Onpro kit, designed to avoid extra clinic visits post-chemotherapy, faced a 22% refusal rate, primarily among Asian patients. Understanding racial differences is key for optimal cancer care delivery.

Keywords:
ChemotherapyFeverLeukopeniaNeutropeniaPegfilgrastimSide effects

More Related Videos

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

2.7K
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.7K

Related Experiment Videos

Last Updated: Jan 21, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.2K
Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

2.7K
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.7K

Area of Science:

  • Oncology
  • Patient Care

Background:

  • The Neulasta Onpro kit offers convenience by eliminating post-chemotherapy clinic visits.
  • Investigating patient acceptance is crucial, especially in racially diverse populations.

Purpose of the Study:

  • To assess the acceptance of the Onpro kit among patients undergoing chemotherapy.
  • To identify potential racial disparities in Onpro kit adoption.

Main Methods:

  • Retrospective review of patients with GI tumors receiving the Onpro kit.
  • Analysis of clinic/nursing notes and pharmacy records for voided orders and refusal reasons.

Main Results:

  • 22% of patients (15/68) refused the Onpro kit, with 87% of these being of Asian race.
  • Reasons for refusal included device discomfort, administration concerns, and fear of side effects.

Conclusions:

  • Significant racial differences exist in Onpro kit acceptance, with Asian patients showing lower adoption rates.
  • Cultural and ethnic factors may influence patient decisions regarding novel medical devices.